VNDA Vanda Pharmaceuticals Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ 10-K/10-Q Aug 6, 2026
$4,01
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$3,8852-Wochen-Tief
$9,9452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$242M
P/E (TTM)
-0.9
EPS (TTM)
$-4.64
Umsatz (TTM)
$216M
Ihre Abzeichen
52W-Spanne
$4–$10
Analystenbewertung
BUY
Kursziel
$12
P/E
-0.9
ROE
-77.8%
Nettogewinnmarge
-127.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
VNDA Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$4.01
Marktkapitalisierung (MRQ)
$242M
P/E (TTM)
-0.9
EPS (TTM)
$-4.64
Umsatz (TTM)
$216M
ROE (TTM)
-77.8%
52W-Spanne
$4–$10
VNDA Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$216M2016-12-31 → 2025-12-31
EPS$-3.742016-12-31 → 2025-12-31
Freier Cashflow$-110M2016-12-31 → 2025-12-31
Nettogewinnmarge-127.4%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | VNDA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -0.95-Jahres-Durchschnitt ≈36.6 | ≈36.6 | · | · | |
| P/S (TTM) | 1.15-Jahres-Durchschnitt ≈2.0 | ≈2.0 | 49.8 | Unterbewertet | |
| K/B (MRQ) | 1.15-Jahres-Durchschnitt ≈1.0 | ≈1.0 | 1.9 | Unterbewertet | |
| Kurs / FCF (TTM) | -1.75-Jahres-Durchschnitt ≈5.0 | ≈5.0 | · | · | |
| Kurs / Cashflow (TTM) | -1.75-Jahres-Durchschnitt ≈4.7 | ≈4.7 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | 2.35-Jahres-Durchschnitt ≈1.3 | ≈1.3 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | VNDA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -86.1%5-Jahres-Durchschnitt ≈-15.9% | ≈-15.9% | -126.3% | Im Einklang | |
| EBITDA Margin (EBITDA-Marge) | -70.0%5-Jahres-Durchschnitt ≈-15.9% | ≈-15.9% | -126.3% | Im Einklang | |
| Vorgewinnmarge (TTM) | -82.1%5-Jahres-Durchschnitt ≈-10.4% | ≈-10.4% | -66.1% | Schwach | |
| Nettogewinnmarge (TTM) | -127.4%5-Jahres-Durchschnitt ≈-19.1% | ≈-19.1% | -177.4% | Spitzenklasse | |
| ROA (TTM) | -53.0%5-Jahres-Durchschnitt ≈-6.8% | ≈-6.8% | -34.5% | Schwach | |
| ROE (TTM) | -77.8%5-Jahres-Durchschnitt ≈-9.9% | ≈-9.9% | -38.2% | Schwach | |
| ROIC | -73.5%5-Jahres-Durchschnitt ≈-14.7% | ≈-14.7% | -39.9% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | VNDA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 1.65-Jahres-Durchschnitt ≈4.8 | ≈4.8 | 7.5 | Geringe Liquidität | |
| Quick Ratio | 1.05-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 6.1 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | VNDA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 8.7%5-Jahres-Durchschnitt ≈-1.9% | ≈-1.9% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -5.3%5-Jahres-Durchschnitt ≈-7.6% | ≈-7.6% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | -2.7% | · | · | · | |
| EPS YoY (EPS VjV) | -63.6%5-Jahres-Durchschnitt ≈-35.5% | ≈-35.5% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -60.0%5-Jahres-Durchschnitt ≈-33.0% | ≈-33.0% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | -54.3% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | -52.4% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | VNDA | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.45-Jahres-Durchschnitt ≈0.4 | ≈0.4 | 0.0 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 4.35-Jahres-Durchschnitt ≈6.2 | ≈6.2 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$405.5K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-2.5%
Nächster Bericht
Okt 27, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 29, 2026 | $-1.04 | $-0.60 | -73.5% |
| 31. März 2026 | $-0.82 | $-0.70 | -16.8% | |
| 31. Dezember 2025 | $-0.46 | $-1.35 | 66.0% | |
| 30. September 2025 | $-0.38 | $-0.46 | 17.8% | |
| 30. Juni 2025 | $-0.46 | $-0.36 | -26.4% | |
| 31. März 2025 | $-0.50 | $-0.61 | 17.8% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $216M | $199M | $193M | $254M | $269M | $248M | $227M | $193M | $165M | $146M | $110M | $50M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | $23M | $2M | |
| R&D Expense | $109M | $74M | $77M | $86M | $75M | $56M | $49M | $44M | $39M | $29M | $29M | $19M | |
| SG&A Expense | $238M | $146M | $113M | $136M | $124M | $141M | $130M | $106M | $124M | $100M | $85M | $85M | |
| Operating Expenses | $367M | $239M | $207M | $248M | $227M | $221M | $204M | $171M | $182M | $165M | $150M | $30M | |
| Operating Income | $-151M | $-41M | $-14M | $6M | $42M | $27M | $23M | $22M | $-17M | $-19M | $-40M | $20M | |
| Pretax Income | $-139M | $-23M | $6M | $11M | $42M | $32M | $29M | $25M | $-15M | $-18M | $-40M | $20M | |
| Income Tax | $82M | $-4M | $4M | $5M | $9M | $8M | $-87M | $138.0K | $136.0K | $104.0K | $0 | $0 | |
| Net Income | $-220M | $-19M | $3M | $6M | $33M | $23M | $116M | $25M | $-16M | $-18M | $-40M | $20M | |
| EPS (Basic) | $-3.74 | $-0.33 | $0.04 | $0.11 | $0.60 | $0.43 | $2.17 | $0.50 | $-0.35 | $-0.41 | $-0.94 | $0.58 | |
| EPS (Diluted) | $-3.74 | $-0.33 | $0.04 | $0.11 | $0.58 | $0.42 | $2.11 | $0.48 | $-0.35 | $-0.41 | $-0.94 | $0.55 | |
| Shares (Basic) | 58,930,157 | 58,149,087 | 57,380,975 | 56,461,877 | 55,548,122 | 54,427,683 | 53,137,562 | 50,859,947 | 44,735,146 | 43,449,441 | 42,250,254 | 34,774,163 | |
| Shares (Diluted) | 58,930,157 | 58,149,087 | 57,557,911 | 56,983,171 | 56,921,836 | 55,190,802 | 54,847,060 | 53,045,257 | 44,735,146 | 43,449,441 | 42,250,254 | 36,686,723 | |
| EBITDA | $-151M | $-41M | $-14M | $6M | $42M | $27M | $23M | $22M | $-17M | $-19M | $-40M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $102M | $136M | $135M | $52M | $61M | $45M | $61M | $34M | $40M | $51M | $61M | |
| Receivables | $55M | $47M | $34M | $34M | $32M | $30M | $26M | $29M | $18M | $20M | $16M | $4M | |
| Inventory | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $994.0K | $840.0K | $779.0K | $1M | $5M | |
| Prepaid Expense | $27M | $15M | $9M | $18M | $12M | $10M | $14M | $12M | $8M | $12M | $6M | $3M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $3M | $2M | $979.0K | $154.0K | |
| Current Assets | $347M | $439M | $433M | $519M | $478M | $409M | $354M | $299M | $170M | $174M | $167M | $142M | |
| PP&E (Net) | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $2M | |
| PP&E (Gross) | $15M | $14M | $13M | $13M | $12M | $12M | $10M | $10M | $10M | $8M | $7M | $4M | |
| Accum. Depreciation | $13M | $12M | $11M | $10M | $9M | $8M | $7M | $5M | $4M | $3M | $2M | $2M | |
| Intangibles | $117M | $114M | $121M | $19M | $20M | $22M | $23M | $25M | $26M | $28M | $39M | $27M | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | · | · | · | $28.0K | |
| Total Assets | $489M | $656M | $648M | $634M | $594M | $533M | $484M | $332M | $205M | $210M | $213M | $172M | |
| Accounts Payable | $68M | $39M | $38M | $46M | $34M | $32M | $28M | $22M | $20M | $16M | $16M | $7M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $7M | |
| Current Liabilities | $145M | $100M | $88M | $91M | $74M | $66M | $60M | $53M | $70M | $50M | $51M | $8M | |
| Capital Leases | $3M | $5M | $7M | $9M | $10M | $11M | $12M | $0 | · | · | · | · | |
| Other Non-current Liabilities | $10M | $10M | $9M | $7M | $4M | $3M | $843.0K | $4M | $4M | $4M | $4M | $3M | |
| Total Liabilities | $162M | $118M | $104M | $107M | $89M | $80M | $73M | $57M | $74M | $79M | $80M | $11M | |
| Common Stock | $59.0K | $58.0K | $58.0K | $57.0K | $56.0K | $55.0K | $54.0K | $52.0K | $45.0K | $44.0K | $43.0K | $41.0K | |
| Retained Earnings | $-395M | $-174M | $-155M | $-158M | $-164M | $-197M | $-221M | $-336M | $-361M | $-346M | $-328M | $-288M | |
| AOCI | $629.0K | $74.0K | $-30.0K | $-1M | $-175.0K | $239.0K | $249.0K | $1.0K | $-34.0K | $58.0K | $39.0K | $16.0K | |
| Stockholders' Equity | $327M | $539M | $545M | $527M | $505M | $453M | $411M | $275M | $131M | $131M | $133M | $161M | |
| Liabilities + Equity | $489M | $656M | $648M | $634M | $594M | $533M | $484M | $332M | $205M | $210M | $213M | $172M | |
| Shares Outstanding | 59,101,630 | 58,310,644 | 57,534,499 | 56,783,764 | 55,900,855 | 54,865,092 | 53,549,612 | 52,477,593 | 44,938,133 | 44,000,614 | 42,815,291 | 41,486,361 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $530.0K | |
| Stock-based Comp | $9M | $12M | $14M | $16M | $15M | $13M | $13M | $12M | $10M | $9M | $8M | $6M | |
| Deferred Tax | $81M | $-6M | $-1M | $1M | $7M | $6M | $-88M | $0 | $0 | $-104.0K | · | · | |
| Amort. of Intangibles | $7M | $7M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $11M | $13M | $2M | |
| Operating Cash Flow | $-109M | $-16M | $13M | $32M | $64M | $52M | $46M | $30M | $-2M | $-8M | $12M | $-82M | |
| CapEx | $998.0K | $490.0K | $383.0K | $679.0K | $552.0K | $2M | $1M | $368.0K | $2M | $1M | $3M | $769.0K | |
| Investing Cash Flow | $95M | $-17M | $-12M | $50M | $-77M | $-41M | $-68M | $-110M | $-10M | · | · | · | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $101M | $0 | $0 | · | $62M | |
| Net Stock Activity | · | · | · | · | · | $0 | $0 | $101M | · | · | · | · | |
| Financing Cash Flow | $-3M | $-155.0K | $0 | $734.0K | $4M | $6M | $6M | $107M | $5M | · | · | · | |
| Net Change in Cash | $-17M | $-34M | $792.0K | $83M | $-9M | $16M | $-16M | $27M | $-7M | $-10M | $-10M | $-4M | |
| Taxes Paid | $-90.0K | $2M | $4M | $0 | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | $-110M | $-16M | $12M | $31M | $64M | $50M | $45M | $30M | $-4M | $-10M | $10M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -70.0% | -20.5% | -7.2% | 2.5% | 15.7% | 11.0% | 10.0% | 11.3% | -10.2% | -12.7% | -36.6% | · | |
| Net Margin | -102.0% | -9.5% | 1.3% | 2.5% | 12.3% | 9.4% | 50.9% | 13.1% | -9.4% | -12.3% | -36.3% | · | |
| Pretax Margin | -64.2% | -11.5% | 3.3% | 4.4% | 15.8% | 12.8% | 12.8% | 13.1% | -9.3% | -12.3% | · | · | |
| EBITDA Margin | -70.0% | -20.5% | -7.2% | 2.5% | 15.7% | 11.0% | 10.0% | 11.3% | -10.2% | -12.7% | -36.6% | · | |
| ROA | -38.5% | -2.9% | 0.39% | 1.0% | 5.9% | 4.6% | 28.3% | 9.4% | -7.5% | -8.5% | -20.7% | · | |
| ROE | -54.2% | -3.5% | 0.46% | 1.2% | 6.6% | 5.2% | 28.5% | 9.4% | -11.8% | -13.6% | -27.1% | · | |
| ROIC | -73.5% | -6.2% | -1.0% | 0.67% | 6.5% | 4.4% | 22.1% | 7.9% | -13.0% | -14.2% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | 4.4 | 4.9 | 5.7 | 6.4 | 6.2 | 6.0 | 5.6 | 2.4 | 3.5 | 3.2 | · | |
| Quick Ratio | 1.0 | 1.5 | 1.9 | 1.8 | 1.1 | 1.4 | 1.2 | 1.7 | 0.7 | 1.2 | 1.3 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 | 0.5 | 0.6 | 0.7 | 0.8 | 0.7 | 0.6 | · | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | 7.3 | · | |
| Receivables Turnover | 4.3 | 4.9 | 5.7 | 7.7 | 8.6 | 8.8 | 8.2 | 8.3 | 8.7 | 8.0 | 11.0 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.54 | $9.24 | $9.47 | $9.28 | $9.03 | $8.26 | $7.67 | $5.25 | $2.92 | $2.98 | $3.11 | · | |
| Revenue / Share | $3.67 | $3.42 | $3.35 | $4.46 | $4.72 | $4.50 | $4.14 | $3.64 | $3.69 | $3.36 | $2.60 | · | |
| Cash Flow / Share | $-1.86 | $-0.27 | $0.22 | $0.56 | $1.13 | $0.94 | $0.84 | $0.57 | $-0.04 | $-0.19 | $0.29 | · | |
| Cash / Share | $1.44 | $1.75 | $2.36 | $2.38 | $0.93 | $1.11 | $0.84 | $1.16 | $0.75 | $0.92 | $1.19 | · | |
| EPS (TTM) | $-3.74 | $-0.33 | $0.04 | $0.11 | $0.58 | $0.42 | $2.11 | $0.48 | $-0.35 | $-0.41 | $-0.94 | $0.55 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.7% | 3.2% | -24.3% | -5.3% | 8.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -5.3% | -9.6% | -8.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -2.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | -63.6% | -81.0% | 38.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | · | · | -54.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | -60.0% | -81.1% | 42.1% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | · | · | -52.4% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $216M | $199M | $193M | $254M | $269M | $248M | $227M | $193M | $165M | $146M | $110M | $50M | |
| Net Income TTM | $-220M | $-19M | $3M | $6M | $33M | $23M | $116M | $25M | $-16M | $-18M | $-40M | $20M | |
| Market Cap | $521M | $279M | $243M | $420M | $877M | $721M | $879M | $1.37B | $683M | $702M | $399M | · | |
| P/E | -2.4 | -14.5 | 105.5 | 67.2 | 27.1 | 31.3 | 7.8 | 54.4 | -43.4 | -38.9 | -9.9 | 26.0 | |
| P/S | 2.4 | 1.4 | 1.3 | 1.6 | 3.3 | 2.9 | 3.9 | 7.1 | 4.1 | 4.8 | 3.6 | · | |
| P/B | 1.6 | 0.5 | 0.4 | 0.8 | 1.7 | 1.6 | 2.1 | 5.0 | 5.2 | 5.3 | 3.0 | · | |
| P / Tangible Book | 2.5 | 0.7 | 0.6 | 0.8 | 1.8 | 1.7 | · | · | · | · | · | · | |
| P / Cash Flow | -4.8 | -17.7 | 19.0 | 13.1 | 13.7 | 13.9 | 19.1 | 45.7 | -344.5 | -86.6 | 32.0 | · | |
| P / FCF | -4.7 | -17.2 | 19.6 | 13.4 | 13.8 | 14.4 | 19.6 | 46.3 | -187.3 | -73.8 | 40.2 | · | |
| Earnings Yield | -42.4% | -6.9% | 0.95% | 1.5% | 3.7% | 3.2% | 12.9% | 1.8% | -2.3% | -2.6% | -10.1% | 3.8% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $51M | $52M | $57M | $56M | $53M | $50M | $53M | $48M | $50M | $47M | $45M | $39M | $46M | $62M | $64M | $65M | |
| R&D Expense | $37M | $28M | $29M | $23M | $22M | $36M | $20M | $17M | $17M | $21M | $24M | $17M | $17M | $19M | $18M | $25M | |
| SG&A Expense | $72M | $68M | $63M | $60M | $65M | $50M | $39M | $38M | $39M | $30M | $24M | $25M | $28M | $36M | $33M | $30M | |
| Operating Expenses | $114M | $102M | $98M | $88M | $91M | $91M | $63M | $59M | $61M | $57M | $52M | $45M | $49M | $60M | $58M | $61M | |
| Operating Income | $-64M | $-50M | $-40M | $-31M | $-39M | $-41M | $-10M | $-11M | $-10M | $-9M | $-7M | $-6M | $-3M | $2M | $7M | $4M | |
| Pretax Income | $-62M | $-48M | $-38M | $-28M | $-35M | $-37M | $-6M | $-6M | $-6M | $-5M | $-2M | $-120.0K | $3M | $6M | $10M | $5M | |
| Income Tax | $129.0K | $143.0K | $103M | $-6M | $-8M | $-8M | $-2M | $-920.0K | $-998.0K | $-518.0K | $739.0K | $-257.0K | $1M | $2M | $3M | $2M | |
| Net Income | $-63M | $-49M | $-141M | $-23M | $-27M | $-29M | $-5M | $-5M | $-5M | $-4M | $-2M | $137.0K | $2M | $3M | $7M | $3M | |
| EPS (Basic) | $-1.04 | $-0.82 | $-2.40 | $-0.38 | $-0.46 | $-0.50 | $-0.09 | $-0.09 | $-0.08 | $-0.07 | $-0.05 | $0.00 | $0.03 | $0.06 | $0.11 | $0.06 | |
| EPS (Diluted) | $-1.04 | $-0.82 | $-2.40 | $-0.38 | $-0.46 | $-0.50 | $-0.09 | $-0.09 | $-0.08 | $-0.07 | $-0.05 | $0.00 | $0.03 | $0.06 | $0.11 | $0.06 | |
| Shares (Basic) | 60,226,570 | 59,459,982 | · | 59,091,478 | 58,993,990 | 58,527,775 | · | 58,261,961 | 58,220,838 | 57,760,940 | · | 57,519,031 | 57,453,916 | 57,011,396 | · | 56,574,503 | |
| Shares (Diluted) | 60,226,570 | 59,459,982 | · | 59,091,478 | 58,993,990 | 58,527,775 | · | 58,261,961 | 58,220,838 | 57,760,940 | · | 57,595,344 | 57,535,615 | 57,400,152 | · | 56,969,033 | |
| EBITDA | $-64M | $-50M | · | $-31M | $-39M | $-41M | · | $-11M | $-10M | $-9M | · | $-6M | $-3M | $2M | · | $4M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $56M | $54M | $85M | $70M | $81M | $112M | $102M | $100M | $103M | $125M | · | $183M | $150M | $354M | · | $49M | |
| Receivables | $60M | $57M | $55M | $51M | $45M | $45M | $47M | $43M | $42M | $37M | · | $29M | $34M | $25M | · | $29M | |
| Inventory | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | · | $1M | $1M | $1M | · | $2M | |
| Prepaid Expense | $33M | $32M | $27M | $21M | $22M | $20M | $15M | $12M | $8M | $7M | · | $16M | $9M | $7M | · | $21M | |
| Current Assets | $264M | $293M | $347M | $367M | $395M | $408M | $439M | $432M | $439M | $439M | · | $537M | $534M | $534M | · | $507M | |
| PP&E (Net) | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $3M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $13M | · | · | · | $12M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $113M | $115M | $117M | $109M | $111M | $112M | $114M | $116M | $118M | $119M | · | $17M | $18M | $18M | · | $19M | |
| Total Assets | $412M | $434M | $489M | $601M | $625M | $632M | $656M | $645M | $651M | $653M | · | $642M | $642M | $645M | · | $622M | |
| Accounts Payable | $70M | $61M | $68M | $48M | $57M | $45M | $39M | $39M | $40M | $38M | · | $33M | $32M | $35M | · | $50M | |
| Current Liabilities | $164M | $136M | $145M | $118M | $121M | $104M | $100M | $89M | $94M | $93M | · | $85M | $87M | $94M | · | $93M | |
| Capital Leases | $15M | $3M | $3M | $3M | $4M | $4M | $5M | $5M | $6M | $7M | · | $7M | $8M | $8M | · | $9M | |
| Other Non-current Liabilities | $10M | $10M | $10M | $11M | $10M | $9M | $10M | $9M | $9M | $9M | · | $6M | $6M | $7M | · | $5M | |
| Total Liabilities | $192M | $153M | $162M | $135M | $138M | $121M | $118M | $104M | $109M | $109M | · | $99M | $102M | $109M | · | $106M | |
| Common Stock | $60.0K | $60.0K | $59.0K | $59.0K | $59.0K | $59.0K | $58.0K | $58.0K | $58.0K | $58.0K | · | $58.0K | $57.0K | $57.0K | · | $57.0K | |
| Retained Earnings | $-506M | $-443M | $-395M | $-254M | $-231M | $-204M | $-174M | $-169M | $-164M | $-160M | · | $-153M | $-153M | $-155M | · | $-165M | |
| AOCI | $38.0K | $212.0K | $629.0K | $540.0K | $396.0K | $383.0K | $74.0K | $702.0K | $-330.0K | $-383.0K | · | $-967.0K | $-865.0K | $-255.0K | · | $-1M | |
| Stockholders' Equity | $220M | $281M | $327M | $466M | $486M | $511M | $539M | $541M | $543M | $544M | $545M | $543M | $540M | $536M | $527M | $516M | |
| Liabilities + Equity | $412M | $434M | $489M | $601M | $625M | $632M | $656M | $645M | $651M | $653M | · | $642M | $642M | $645M | · | $622M | |
| Shares Outstanding | 60,454,687 | 60,135,062 | 59,101,630 | 59,095,630 | 59,080,630 | 58,933,982 | 58,310,644 | 58,306,144 | 58,287,308 | 58,196,523 | 57,534,499 | 57,529,499 | 57,496,913 | 57,440,992 | 56,783,764 | 56,588,548 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $3M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | $3M | $4M | $4M | $4M | |
| Deferred Tax | $0 | $0 | $103M | $-6M | $-8M | $-8M | $-2M | $-3M | $-1M | $-246.0K | $-7M | $3M | $1M | $2M | $417.0K | $-2M | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $953.0K | $380.0K | $378.0K | $379.0K | $379.0K | $379.0K | |
| Operating Cash Flow | $-31M | $-50M | $-29M | $-32M | $-15M | $-33M | $-2M | $-15M | $-7M | $8M | $-4M | $-2M | $-13M | $32M | $9M | $13M | |
| CapEx | $190.0K | $221.0K | $102.0K | $161.0K | $299.0K | $436.0K | $214.0K | $161.0K | $108.0K | $7.0K | $253.0K | $24.0K | $55.0K | $51.0K | $263.0K | $148.0K | |
| Investing Cash Flow | $34M | $20M | $45M | $21M | $-15M | $44M | $4M | $12M | $-15M | $-18M | $-44M | $35M | $-191M | $187M | $75M | $-22M | |
| Financing Cash Flow | $-856.0K | $-776.0K | $-640.0K | $-517.0K | $-425.0K | $-1M | $-155.0K | $0 | $0 | $0 | $0 | $0 | · | · | $605.0K | $4.0K | |
| Net Change in Cash | $2M | $-31M | $15M | $-11M | $-31M | $9M | $2M | $-2M | $-22M | $-11M | $-47M | $33M | $-204M | $219M | $86M | $-9M | |
| Free Cash Flow | · | $-50M | · | · | · | $-34M | · | · | · | $8M | · | · | · | $32M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -126.3% | -97.1% | · | -55.6% | -73.2% | -82.0% | · | -23.1% | -20.1% | -19.5% | · | -15.4% | -6.2% | 3.2% | · | 6.0% | |
| Net Margin | -123.7% | -93.9% | · | -40.2% | -51.7% | -58.9% | · | -11.2% | -8.9% | -8.7% | · | 0.35% | 3.3% | 5.2% | · | 5.0% | |
| Pretax Margin | -123.5% | -93.6% | · | -50.5% | -66.3% | -74.7% | · | -13.1% | -10.9% | -9.8% | · | -0.31% | 5.6% | 8.8% | · | 8.4% | |
| EBITDA Margin | -126.3% | -97.1% | · | -55.6% | -73.2% | -82.0% | · | -23.1% | -20.1% | -19.5% | · | -15.4% | -6.2% | 3.2% | · | 6.0% | |
| ROA | -12.0% | -9.1% | · | -3.6% | -4.3% | -4.6% | · | -0.83% | -0.70% | -0.64% | · | 0.02% | 0.24% | 0.52% | · | 0.54% | |
| ROE | -17.7% | -12.3% | · | -4.5% | -5.3% | -5.6% | · | -0.98% | -0.83% | -0.77% | · | 0.03% | 0.29% | 0.63% | · | 0.65% | |
| ROIC | -29.0% | -17.9% | · | -5.3% | -6.2% | -6.3% | · | -1.7% | -1.5% | -1.5% | · | 1.3% | -0.31% | 0.22% | · | 0.45% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | 2.2 | · | 3.1 | 3.3 | 3.9 | · | 4.9 | 4.7 | 4.7 | · | 6.3 | 6.1 | 5.7 | · | 5.5 | |
| Quick Ratio | 0.7 | 0.8 | · | 1.0 | 1.0 | 1.5 | · | 1.6 | 1.5 | 1.7 | · | 2.5 | 2.1 | 4.0 | · | 0.9 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.0 | 1.0 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | 1.3 | 1.6 | · | 1.3 | 1.5 | 2.3 | · | 1.8 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.64 | $4.67 | · | $7.89 | $8.23 | $8.68 | · | $9.28 | $9.31 | $9.35 | · | $9.44 | $9.39 | $9.33 | · | $9.11 | |
| Revenue / Share | $0.84 | $0.87 | · | $0.95 | $0.89 | $0.85 | · | $0.82 | $0.87 | $0.82 | · | $0.67 | $0.80 | $1.09 | · | $1.15 | |
| Cash Flow / Share | · | $-0.84 | · | · | · | $-0.57 | · | · | · | $0.13 | · | · | · | $0.55 | · | · | |
| Cash / Share | $0.92 | $0.90 | · | $1.18 | $1.37 | $1.90 | · | $1.72 | $1.77 | $2.15 | · | $3.18 | $2.61 | $6.17 | · | $0.87 | |
| EPS (TTM) | $-4.64 | $-4.06 | · | $-1.43 | $-1.14 | $-0.76 | · | $-0.29 | $-0.20 | $-0.09 | · | $0.20 | $0.26 | $0.28 | · | $0.12 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $216M | $218M | · | $212M | $203M | $201M | · | $191M | $182M | $178M | · | $212M | $238M | $257M | · | $258M | |
| Net Income TTM | $-275M | $-240M | · | $-84M | $-67M | $-44M | · | $-16M | $-11M | $-5M | · | $12M | $15M | $16M | · | $6M | |
| Market Cap | $370M | $416M | · | $295M | $279M | $271M | · | $273M | $329M | $239M | · | $249M | $379M | $390M | · | $559M | |
| P/E | -1.3 | -1.7 | · | -3.5 | -4.1 | -6.0 | · | -16.2 | -28.2 | -45.7 | · | 21.6 | 25.3 | 24.2 | · | 82.3 | |
| P/S | 1.7 | 1.9 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.8 | 1.3 | · | 1.2 | 1.6 | 1.5 | · | 2.2 | |
| P/B | 1.7 | 1.5 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.6 | 0.4 | · | 0.5 | 0.7 | 0.7 | · | 1.1 | |
| P / Tangible Book | 3.5 | 2.5 | · | 0.8 | 0.7 | 0.7 | · | 0.6 | 0.8 | 0.6 | · | 0.5 | 0.7 | 0.8 | · | 1.1 | |
| P / Cash Flow | · | -8.3 | · | · | · | -8.2 | · | · | · | 31.6 | · | · | · | 12.3 | · | · | |
| Earnings Yield | -75.8% | -58.8% | · | -28.7% | -24.1% | -16.6% | · | -6.2% | -3.5% | -2.2% | · | 4.6% | 4.0% | 4.1% | · | 1.2% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $216M | $199M | $193M | $254M | $269M |
| Betriebsgewinnmarge % | -70.0% | -20.5% | -7.2% | 2.5% | 15.7% |
| Nettoergebnis | $-220M | $-19M | $3M | $6M | $33M |
| Verwässerte EPS | $-3.74 | $-0.33 | $0.04 | $0.11 | $0.58 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.4 | 4.4 | 4.9 | 5.7 | 6.4 |
| Quick Ratio | 1.0 | 1.5 | 1.9 | 1.8 | 1.1 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-110M | $-16M | $12M | $31M | $64M |
Institutionelle Eigentümer (13F) 180 Einreicher · $324.9M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
180
Gehaltener Wert
$324.9M
Neue Positionen
29
Geschlossene Positionen
24
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 29 (-22 vs. Vorquartal) | 24 (-6 vs. Vorquartal) | 67 (+7 vs. Vorquartal) | 57 (+15 vs. Vorquartal) | +3.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $46.840.870 | 7.653.737 | 14,42% | Aktien |
| VANGUARD GROUP INC | $32.914.925 | 3.731.851 | 10,13% | Aktien |
| STATE STREET CORP | $21.520.399 | 3.516.405 | 6,62% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $21.405.893 | 3.497.695 | 6,59% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $21.061.129 | 3.441.361 | 6,48% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $15.447.125 | 2.524.040 | 4,75% | Aktien |
| AIGH Capital Management LLC | $12.510.315 | 2.044.169 | 3,85% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $10.572.544 | 1.727.349 | 3,25% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $9.809.216 | 1.602.813 | 3,02% | Aktien |
| TWO SIGMA ADVISERS, LP | $9.254.826 | 1.049.300 | 2,85% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $9.082.993 | 1.483.787 | 2,80% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $8.256.321 | 1.349.072 | 2,54% | Aktien |
| MARSHALL WACE, LLP | $7.503.094 | 1.225.996 | 2,31% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $7.425.555 | 1.213.326 | 2,29% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.921.928 | 1.131.034 | 2,13% | Aktien |
| GOLDMAN SACHS GROUP INC | $6.341.911 | 1.036.260 | 1,95% | Aktien |
| CITADEL ADVISORS LLC | $4.640.808 | 758.302 | 1,43% | Aktien |
| Qube Research & Technologies Ltd | $4.462.777 | 729.212 | 1,37% | Aktien |
| FEDERATED HERMES, INC. | $4.371.381 | 714.278 | 1,35% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.955.087 | 646.256 | 1,22% | Aktien |
| NORTHERN TRUST CORP | $3.675.788 | 600.619 | 1,13% | Aktien |
| MORGAN STANLEY | $2.925.200 | 477.974 | 0,90% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.446.880 | 399.817 | 0,75% | Aktien |
| Jump Financial, LLC | $2.080.231 | 339.907 | 0,64% | Aktien |
| Quantinno Capital Management LP | $1.920.383 | 313.788 | 0,59% | Aktien |
| Point72 Asset Management, L.P. | $1.905.535 | 311.362 | 0,59% | Aktien |
| UBS Group AG | $1.855.530 | 303.191 | 0,57% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1.854.978 | 303.101 | 0,57% | Aktien |
| JPMORGAN CHASE & CO | $1.797.326 | 292.724 | 0,55% | Aktien |
| IEQ CAPITAL, LLC | $1.730.607 | 282.779 | 0,53% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $1.451.566 | 237.184 | 0,45% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $1.436.933 | 234.793 | 0,44% | Aktien |
| Monaco Asset Management SAM | $1.354.270 | 221.286 | 0,42% | Aktien |
| AMERIPRISE FINANCIAL INC | $1.326.865 | 216.808 | 0,41% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $1.317.061 | 215.206 | 0,41% | Aktien |
| BANK OF AMERICA CORP /DE/ | $1.301.621 | 212.683 | 0,40% | Aktien |
| Mariner, LLC | $1.061.705 | 173.480 | 0,33% | Aktien |
| Bank of New York Mellon Corp | $1.039.093 | 169.786 | 0,32% | Aktien |
| Invesco Ltd. | $976.795 | 159.607 | 0,30% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $970.638 | 158.601 | 0,30% | Aktien |
| Man Group plc | $939.769 | 153.557 | 0,29% | Aktien |
| KOTLER KEVIN | $882.000 | 100.000 | 0,27% | Aktien |
| KLP KAPITALFORVALTNING AS | $828.648 | 135.400 | 0,26% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $749.982 | 122.546 | 0,23% | Aktien |
| Jefferies Financial Group Inc. | $749.253 | 122.427 | 0,23% | Aktien |
| Trexquant Investment LP | $741.077 | 121.091 | 0,23% | Aktien |
| Cerity Partners LLC | $722.020 | 117.977 | 0,22% | Aktien |
| Nuveen, LLC | $719.112 | 117.502 | 0,22% | Aktien |
| Corient Private Wealth LP | $626.438 | 102.359 | 0,19% | Aktien |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $622.098 | 101.650 | 0,19% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Tang Capital Partners, LP, Tang Capital Management, LLC, Kevin C. Tang ×3 Einreichungen | 18. Februar 2009 | · | Erste Einreichung | Vorstandskampagne | SEC |
| Care Capital, LLC, Care Capital II, LLC, Care Capital Offshore Investments II, LP, Care Capital Investments II, LP, Jan Leschly, David Ramsay, Argeris Karabelas | 13. Februar 2007 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 45 Insider · 18 Führungskräfte · 16 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kevin Patrick Moran | SVP, CFO & Treasurer | 2. März 2026 S | 411.380 | 0 | 1 | $-350.995 |
| James Patrick Kelly | EVP & Chief Financial Officer | 3. März 2020 S | 186.869 | 0 | 0 | $0 |
| Stephanie Rast Irish | Acting CFO/Treasurer | 19. Februar 2010 S | 2.249 | 0 | 0 | $0 |
| Steven A Shallcross | Sr. VP, CFO, Treasurer | 4. Januar 2008 A | 0 | 0 | 0 | $0 |
| McGuire Daniel Patrick | SVP, GC and Secretary | 4. Juni 2026 A | 109.982 | 0 | 0 | $0 |
| Joakim Wijkstrom | SVP, Chief Marketing Officer | 2. März 2026 S | 333.469 | 0 | 1 | $-254.716 |
| Timothy Williams | SVP & General Counsel | 2. März 2026 S | 377.450 | 0 | 1 | $-350.929 |
| Gunther Birznieks | SVP, Business Development | 2. März 2026 S | 494.197 | 0 | 1 | $-350.904 |
| Aranthan Jones II | Chief Corp. Affairs Officer | 15. September 2021 M | 81.980 | 0 | 0 | $0 |
| Gian Piero Reverberi | SVP & Chief Commercial Officer | 2. März 2020 S | 165.384 | 0 | 0 | $0 |
| Richard L. Gulino | SVP, General Counsel & Sec. | 28. Februar 2018 A | 115.073 | 0 | 0 | $0 |
| Paolo Baroldi | SVP & Chief Medical Officer | 3. Januar 2017 M | 54.365 | 0 | 0 | $0 |
| Thomas Edward Gibbs | SVP, Chief Commercial Officer | 20. April 2015 A | · | 0 | 0 | $0 |
| Robert Repella | SVP & Chief Commercial Officer | 21. November 2013 M | 15.000 | 0 | 0 | $0 |
| John Joseph Feeney | SVP & Chief Medical Officer | 16. Februar 2012 S | 11.942 | 0 | 0 | $0 |
| William D Clark | Sr. VP, Chief Business Officer | 19. Februar 2010 S | 168.279 | 0 | 0 | $0 |
| Albert W. Gianchetti | Sr.VP,Chief Commercial Officer | 4. Januar 2008 A | 3.000 | 0 | 0 | $0 |
| Deepak Shripad Phadke | Vice President Manufacturing | 12. Dezember 2006 M | 0 | 0 | 0 | $0 |
| Charles Cliff Duncan | Direktor | 4. Juni 2026 A | 98.701 | 0 | 0 | $0 |
| Tage Honore | Direktor | 4. Juni 2026 A | 135.069 | 0 | 1 | $-240.900 |
| Stephen Ray Mitchell | Direktor | 4. Juni 2026 A | 112.846 | 0 | 0 | $0 |
| Anne Sempowski Ward | Direktor | 4. Juni 2026 A | 160.667 | 0 | 0 | $0 |
| Phaedra Chrousos | Direktor | 4. Juni 2026 A | 164.950 | 0 | 0 | $0 |
| Richard W Dugan | Direktor | 4. Juni 2026 A | 219.054 | 0 | 0 | $0 |
| Thomas Watkins | Direktor | 2. Juni 2022 M | 63.064 | 0 | 0 | $0 |
| Michael F Cola | Direktor | 13. Juni 2019 A | 15.000 | 0 | 0 | $0 |
| Vincent Milano | Direktor | 13. Juni 2018 A | 10.000 | 0 | 0 | $0 |
| Kenneth Bate | Direktor | 15. Juni 2017 A | 5.000 | 0 | 0 | $0 |
| Howard H Pien | Direktor | 18. Juni 2015 A | · | 0 | 0 | $0 |
| Steven K Galson | Direktor | 22. Mai 2014 A | · | 0 | 0 | $0 |
| Argeris N Karabelas | Direktor | 16. Juni 2011 A | 0 | 0 | 0 | $0 |
| Brian K Halak | Direktor | 26. März 2010 J | 7.276 | 0 | 0 | $0 |
| James B Tananbaum | Direktor | 16. Mai 2007 A | 11.041 | 0 | 0 | $0 |
| Wayne T Hockmeyer | Direktor | 18. April 2006 C | 1.601.798 | 0 | 0 | $0 |
| DP VI Associates, L.P. | 10%-Eigentümer | 12. Dezember 2006 S | 21.068 | 0 | 0 | $0 |
| Domain Partners VI, L.P. | 10%-Eigentümer | 12. Dezember 2006 J | 1.954.450 | 0 | 0 | $0 |
| Robert J More | 10%-Eigentümer | 12. Dezember 2006 S | 21.068 | 0 | 0 | $0 |
| Kathleen K Schoemaker | 10%-Eigentümer | 12. Dezember 2006 S | 21.068 | 0 | 0 | $0 |
| Brian H Dovey | 10%-Eigentümer | 12. Dezember 2006 S | 21.068 | 0 | 0 | $0 |
| Nicole Vitullo | 10%-Eigentümer | 12. Dezember 2006 S | 21.068 | 0 | 0 | $0 |
| BLAIR JAMES C | 10%-Eigentümer | 12. Dezember 2006 S | 21.068 | 0 | 0 | $0 |
| TREU JESSE I | 10%-Eigentümer | 12. Dezember 2006 S | 21.068 | 0 | 0 | $0 |
| MEDIMMUNE INC /DE | 10%-Eigentümer | 18. April 2006 C | 1.601.798 | 0 | 0 | $0 |
| Mihael Hristos Polymeropoulos | · | 2. März 2026 S | 2.704.496 | 0 | 1 | $-1.276.440 |
| David Russ Ramsay | · | 12. März 2010 S | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 30 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,42% | 21.391 SH | 23. Oktober 2026 | Täglich |
| IBRN · iShares Trust | 0,30% | 4.456 SH | 11. September 2026 | Täglich |
| HAPS · Harbor ETF Trust | 0,15% | 51.449 NS | 31. Juli 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,09% | 101.215 SH | 19. August 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,08% | 77.872 NS | 31. Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,08% | 256.365 SH | 19. August 2026 | Täglich |
| IWC · iShares Trust | 0,06% | 182.510 SH | 11. September 2026 | Täglich |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 38.117 NS | 31. Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,02% | 1.064 NS | 31. Juli 2026 | N-PORT |
| IBB · iShares Trust | 0,02% | 429.035 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 46.913 SH | 19. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 124.172 SH | 23. Oktober 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 4.544 SH | 23. Oktober 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 309.952 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 1.378.144 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 25.631 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 188.354 NS | 31. Juli 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,00% | 63.637 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2.824 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 162.080 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6.317 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 118.715 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 15.271 SH | 3. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 10.453 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 12.885 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 703.477 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.761.840 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 5.171 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 155.868 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 513.341 SH | 11. September 2026 | Täglich |
VNDA Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 11 Analysten
KAUF
Median-Ziel
$11.00
+174,3%
3 27,3%
Starker Kauf
6 54,5%
Kauf
2 18,2%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
5 Analysten · 2026-10-19Mittelwert-Ziel $11.75 +193,0%
← Unter allen Zielen
Aktueller Preis $4.01
Tief$5.75
Mittelwert$11.75
Hoch$20.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | · |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | · |
| RCKT | · | · | · | · | · | · |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | · |
| CABA | $220M | -1.0 | · | · | -115.5% | · |
| LRMR | $317M | -2.2 | · | · | -167.4% | · |
| IMRX | · | -5.2 | · | · | -45.3% | · |
| GLSI | $300M | -14.7 | · | · | -2159.7% | · |
| PALI | $375M | -7.8 | · | · | -25.4% | · |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| LXEO | $725M | -5.3 | · | · | -51.9% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 6, 2026